Kraig Biocraft Laboratories, a US-based leader in spider silk technology, has announced significant progress in its largest-ever production batch of recombinant spider silk. The company confirmed it has completed the first half of this milestone cycle, with the harvested spider silk cocoons now being prepped for reeling into finished silk. The second half of the production is expected to conclude within the next two weeks.

This production run marks a major step forward, as it is the first time Kraig Labs has run simultaneous batches of its BAM-1 hybrid silkworms in its newly expanded facilities. Early results have shown strong performance from the BAM-1 hybrids and demonstrated the efficiency and scalability of the upgraded infrastructure.

The company has also successfully completed the production of all BAM-1 hybrid eggs planned for release in the coming month. This ensures a continuous and high-quality supply of silkworms to support its future production goals for 2025.

Kim Thompson, Founder and CEO, highlighted the achievement as proof of Kraig Labs ability to shift from batch-based processing to a scalable, continuous flow model. This, he noted, positions the company to accelerate the commercialization of its eco-friendly, high-strength spider silk fibers.

Kraig Labs remains focused on expanding its production capabilities and bringing sustainable spider silk to the performance textiles market. Further updates on production and commercialization will follow as the company continues to scale.